PAPL Q3 2025 Earnings Narrowed Loss Beats Estimates by 51 COFS Q1 2026 Earnings Earnings Beat Estimates as EPS Surpasses Consensus ORLY Q1 2026 Earnings EPS Beat Provides Mixed Sentiment Amid Broader Market Pullback Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns PRCT Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Investor Sentiment MSDL Q1 2026 Earnings Narrow Earnings Beat as Stock Slips